Published in Lancet on August 25, 2001
Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med (2004) 2.12
Mannose-binding lectin in prediction of susceptibility to infection. Lancet (2001) 2.02
Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev (2010) 1.70
Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk. J Exp Med (2004) 1.30
A population-based study of morbidity and mortality in mannose-binding lectin deficiency. J Exp Med (2004) 1.21
Mannan-binding-lectin-associated serine proteases, characteristics and disease associations. Springer Semin Immunopathol (2005) 1.17
Deficiency of mannose-binding lectin greatly increases susceptibility to postburn infection with Pseudomonas aeruginosa. J Immunol (2006) 1.11
Mannose binding lectin acute phase activity in patients with severe infection. J Clin Immunol (2005) 1.09
Phase I safety, tolerability, and pharmacokinetic study of recombinant human mannan-binding lectin. J Clin Immunol (2006) 1.09
Interactions between mannose-binding lectin and MASPs during complement activation by the lectin pathway. Immunobiology (2006) 1.07
No strong relationship between mannan binding lectin or plasma ficolins and chemotherapy-related infections. Clin Exp Immunol (2003) 1.04
Influence of major surgery on the mannan-binding lectin pathway of innate immunity. Clin Exp Immunol (2006) 0.99
Mannan binding lectin in febrile adults: no correlation with microbial infection and complement activation. J Clin Pathol (2003) 0.95
Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia. Support Care Cancer (2010) 0.95
Species distribution and antimicrobial susceptibility of gram-negative aerobic bacteria in hospitalized cancer patients. J Transl Med (2009) 0.94
Low mannose-binding lectin (MBL) levels in neonates with pneumonia and sepsis. Clin Exp Immunol (2007) 0.94
Common variable immunodeficiency and the complement system; low mannose-binding lectin levels are associated with bronchiectasis. Clin Exp Immunol (2005) 0.91
Mannan-binding lectin and procalcitonin measurement for prediction of postoperative infection. Crit Care (2005) 0.91
Deficiency of functional mannose-binding lectin is not associated with infections in patients with systemic lupus erythematosus. Arthritis Res Ther (2006) 0.90
An enzyme-linked immunosorbent assay (ELISA) for quantification of human collectin 11 (CL-11, CL-K1). J Immunol Methods (2011) 0.89
Mannose-binding lectin does not act as an acute-phase reactant in adults with community-acquired pneumococcal pneumonia. Clin Exp Immunol (2006) 0.88
The role of mannose-binding lectin in severe sepsis and septic shock. Mediators Inflamm (2013) 0.87
Mitochondria and the lectin pathway of complement. J Biol Chem (2013) 0.86
H-ficolin serum concentration and susceptibility to fever and neutropenia in paediatric cancer patients. Clin Exp Immunol (2009) 0.85
Mannose-binding lectin 2 polymorphisms do not influence frequency or type of infection in adults with chemotherapy induced neutropaenia. PLoS One (2012) 0.85
Mannose-binding lectin levels and major infections in a cohort of very long-term survivors after allogeneic stem cell transplantation. Haematologica (2010) 0.83
Management of febrile neutropenia in the era of bacterial resistance. Ther Adv Infect Dis (2013) 0.82
Mannan-binding lectin in children with Escherichia coli O157:H7 haemmorrhagic colitis and haemolytic uraemic syndrome. Clin Exp Immunol (2003) 0.82
Mannose-binding lectin gene polymorphic variants predispose to the development of bronchopulmonary complications but have no influence on other clinical and laboratory symptoms or signs of common variable immunodeficiency. Clin Exp Immunol (2008) 0.82
Mannose-binding lectin genotype and serum levels in patients with chronic and allergic pulmonary aspergillosis. Int J Immunogenet (2012) 0.80
Is there a role for mannan/mannose-binding lectin (MBL) in defence against infection following chemotherapy for cancer? Clin Exp Immunol (2004) 0.80
Mannose-binding lectin and maladies of the bowel and liver. World J Gastroenterol (2006) 0.79
Mannose-binding lectin genotypes: lack of association with susceptibility to thoracic empyema. BMC Med Genet (2010) 0.79
M-ficolin levels are associated with the occurrence of severe infections in patients with haematological cancer undergoing chemotherapy. Clin Exp Immunol (2012) 0.79
The emerging role of complement lectin pathway in trypanosomatids: molecular bases in activation, genetic deficiencies, susceptibility to infection, and complement system-based therapeutics. ScientificWorldJournal (2013) 0.78
Mannose-binding lectin (MBL) as prognostic factor in paediatric oncology patients. Clin Exp Immunol (2011) 0.77
Effects of mannose-binding lectin polymorphisms on irinotecan-induced febrile neutropenia. Oncologist (2010) 0.77
Mannose-binding lectin in HIV infection. Future Virol (2008) 0.77
Mannose-binding lectin gene variants and infections in patients receiving autologous stem cell transplantation. BMC Immunol (2014) 0.76
Low mannose-binding lectin complement activation function is associated with predisposition to Legionnaires' disease. Clin Exp Immunol (2007) 0.76
The High Prevalence of Functional Complement Defects Induced by Chemotherapy. Front Immunol (2016) 0.75
Association of mannose-binding lectin levels and invasive fungal disease in hematologic malignancy patients receiving myelosuppressive chemotherapy or allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant (2016) 0.75
Early Changes of Mannose-Binding Lectin, H-Ficolin, and Procalcitonin in Patients with Febrile Neutropenia: A Prospective Observational Study. Turk J Haematol (2015) 0.75
Mannose-Binding Lectin: Biologic Characteristics and Role in the Susceptibility to Infections and Ischemia-Reperfusion Related Injury in Critically Ill Neonates. J Immunol Res (2017) 0.75
HBV Viral Load and Liver Enzyme Levels May Be Associated with the Wild MBL2 AA Genotype. Mediators Inflamm (2017) 0.75
The association of mannose-binding lectin 2 polymorphisms with outcome in very low birth weight infants. PLoS One (2017) 0.75
Prevention of eczema. Lancet (1977) 4.89
Transient IgA deficiency and pathogenesis of infantile atopy. Lancet (1973) 4.07
Is migraine food allergy? A double-blind controlled trial of oligoantigenic diet treatment. Lancet (1983) 3.79
Infection and sudden unexpected death in infancy: a systematic retrospective case review. Lancet (2008) 3.44
Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet (1989) 3.12
Molecular basis of opsonic defect in immunodeficient children. Lancet (1991) 3.00
Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ (1997) 2.93
The Portex EpiFuse epidural connector: lessons on first use in a large district general hospital. Anaesthesia (2011) 2.87
Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun (2000) 2.71
Randomized clinical trial of glutamine-supplemented versus standard parenteral nutrition in infants with surgical gastrointestinal disease. Br J Surg (2012) 2.61
Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet (1995) 2.41
Immune exclusion is a function of IgA. Nature (1975) 2.36
Management of Kawasaki disease. Arch Dis Child (2013) 2.30
Subfragments from the Fc fragment of human immunoglobulin G. Isolation and physicochemical charaterization. Biochem J (1968) 2.26
Predisposing factors and the development of reaginic allergy in infancy. Clin Allergy (1976) 2.15
Defective yeast opsonization and C2 deficiency in atopic patients. Clin Exp Immunol (1978) 2.14
High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet (1992) 2.09
Inherited prothrombotic states and ischaemic stroke in childhood. J Neurol Neurosurg Psychiatry (1998) 2.06
Mutation of gene of mannose-binding protein associated with chronic hepatitis B viral infection. Lancet (1996) 2.01
Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol Rev (2001) 1.90
Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Methods (2004) 1.78
HLA antigens and atopic features in steroid-responsive nephrotic syndrome of childhood. Lancet (1976) 1.73
Atopy does not predispose to RSV bronchiolitis or postbronchiolitic wheezing. Br Med J (Clin Res Ed) (1981) 1.73
Mannose-binding lectin in innate immunity: past, present and future. Tissue Antigens (2006) 1.66
Disruption of sulphated glycosaminoglycans in intestinal inflammation. Lancet (1993) 1.64
Studies on immunoglobulins of Nigerians. I. The immunoglobulin levels of a Nigerian population. J Trop Med Hyg (1966) 1.59
Intestinal sugar permeability: relationship to diarrhoeal disease and small bowel morphology. J Pediatr Gastroenterol Nutr (1985) 1.57
Mannose-binding lectin is present in the infected airway: a possible pulmonary defence mechanism. Thorax (2008) 1.54
Endotoxin immunity and the development of the systemic inflammatory response syndrome in critically ill children. Intensive Care Med (2006) 1.52
IgG antigens of the C gamma 2 and C gamma 3 homology regions interacting with rheumatoid factors. Clin Exp Immunol (1972) 1.51
Nijmegen breakage syndrome diagnosed as Fanconi anaemia. Pediatr Blood Cancer (2005) 1.50
Soluble antigens in the blood of African patients with severe plasmodium falciparum malaria. Lancet (1968) 1.50
Pepsin digestion of human G-myeloma proteins of different subclasses. I. The characteristic features of pepsin cleavage as a function of time. Clin Exp Immunol (1970) 1.50
Branhamella catarrhalis: antigenic determinants and the development of the IgG subclass response in childhood. J Infect Dis (1990) 1.49
Emergency management of meningitis. J R Soc Med (2000) 1.49
Autoimmune enteropathy with distinct mucosal features in T-cell activation deficiency: the contribution of T cells to the mucosal lesion. J Pediatr Gastroenterol Nutr (1999) 1.47
Localization of Gm markers to different molecular regions of the Fc fragment. Clin Exp Immunol (1971) 1.44
The level of mannan-binding protein regulates the binding of complement-derived opsonins to mannan and zymosan at low serum concentrations. Clin Exp Immunol (1990) 1.37
Pseudomonas infection, allergy, and cystic fibrosis. Arch Dis Child (1982) 1.37
Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J Infect Dis (2001) 1.35
Immunoglobulin D in serum, body fluids and lymphoid tissues. Clin Exp Immunol (1968) 1.34
Localisation of monocyte binding site of human immunoglobulin G. Nature (1974) 1.30
Scottish validation study of Cancer Registration data childhood leukaemia 1968-1981--I. Leuk Res (1987) 1.27
Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype. Immunology (1995) 1.23
Immunological studies in cystic fibrosis. Arch Dis Child (1978) 1.20
Increased intestinal permeability in atopic eczema. J Invest Dermatol (1986) 1.19
The generation of a 'tolerogen' after the ingestion of ovalbumin is time-dependent and unrelated to serum levels of immunoreactive antigen. Clin Exp Immunol (1990) 1.19
Antibodies of IgA and IgG class in normal human urine. Immunology (1967) 1.19
A study of C3b deposition on yeast surfaces by sera of known opsonic potential. Clin Exp Immunol (1981) 1.18
Anti-microbial activities of mannose-binding lectin. Biochem Soc Trans (2003) 1.16
HLA in eczema and hay fever. Clin Exp Immunol (1977) 1.15
Activation of complement by mannose-binding lectin on isogenic mutants of Neisseria meningitidis serogroup B. J Immunol (1998) 1.13
Impaired pulmonary status in cystic fibrosis adults with two mutated MBL-2 alleles. Eur Respir J (2004) 1.12
Rheumatoid anti Gm gactors with specificity for the pFc' subfragment of human immunoglobulin G. Nature (1970) 1.11
Suboptimal C3b/C3bi deposition and defective yeast opsonization. I. Evidence for the absence of essential co-factor activity. Clin Exp Immunol (1985) 1.10
The disease of the NZB mouse. I. Examination of ovum fusion derived tetraparental NZB:CFW chimaeras. Clin Exp Immunol (1972) 1.09
Studies on the immunology of human malaria. I. Preliminary characterization of antigens in Plasmodium falciparum infections. Clin Exp Immunol (1969) 1.08
Circulating platelet-neutrophil complexes represent a subpopulation of activated neutrophils primed for adhesion, phagocytosis and intracellular killing. Br J Haematol (1999) 1.07
Whole blood model of meningococcal bacteraemia--a method for exploring host-bacterial interactions. Microb Pathog (1995) 1.07
Poststreptococcal acute disseminated encephalomyelitis with basal ganglia involvement and auto-reactive antibasal ganglia antibodies. Ann Neurol (2001) 1.06
CNS-directed therapy for childhood acute lymphoblastic leukemia: Childhood ALL Collaborative Group overview of 43 randomized trials. J Clin Oncol (2003) 1.06
A naturally occurring fragment related to the heavy chains of immunoglobulin G in normal human urine. Nature (1966) 1.06
Human constant regions influence the antibody binding characteristics of mouse-human chimeric IgG subclasses. Immunology (1996) 1.05
Infant feeding and atopy. Lancet (1982) 1.04
Simple method of subtyping human G-myeloma proteins based on sensitivity to pepsin digestion. Nature (1970) 1.03
The lipopolysaccharide structures of Salmonella enterica serovar Typhimurium and Neisseria gonorrhoeae determine the attachment of human mannose-binding lectin to intact organisms. Infect Immun (2000) 1.03
Genetic (Gm) antigens associated with subfragments from the Fc fragment of human immunoglobulin G. Nature (1969) 1.02
Assessment of immune response to meningococcal disease: comparison of a whole-blood assay and the serum bactericidal assay. Microb Pathog (1999) 1.02
Deficiency of prostacyclin production in meningococcal shock. Arch Dis Child (1991) 1.01
Platelet and leucocyte activation in childhood sickle cell disease: association with nocturnal hypoxaemia. Br J Haematol (2000) 1.01
Determination of IgG antiglobulins in rheumatoid disease using insolubilized human IgG. Clin Exp Immunol (1973) 1.01
Specific suppression of rat IgE responses with milk from immunized females and with feeds of serum antibody. Immunology (1983) 1.01
The role of pH in modified ELISA procedures used for the estimation of functional antibody affinity. J Immunol Methods (1993) 1.01
Polymorphonuclear neutrophil iodination response as an estimate of defective yeast opsonization. Clin Exp Immunol (1981) 1.00
A controlled trial of hyposensitization with adsorbed tyrosine Dermatophagoides pteronyssinus antigen in childhood asthma: in vivo aspects. Clin Allergy (1984) 1.00
Correlation between the avidity of mouse-human chimeric IgG subclass monoclonal antibodies measured by solid-phase elution ELISA and biospecific interaction analysis (BIA). J Immunol Methods (1997) 0.99
In vitro investigations in asthmatic children undergoing hyposensitization with tyrosine-adsorbed Dermatophagoides pteronyssinus antigen. Clin Allergy (1984) 0.99
Association of Gm allotypes with the antibody response to the outer membrane proteins of a common upper respiratory tract organism, Moraxella catarrhalis. J Immunol (1994) 0.98
Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome. Arch Dis Child (1996) 0.98
Association of house-dust and grass-pollen allergies with specific IgA antibody deficiency. Lancet (1974) 0.98
The release of Fe' and pFc' fragments from human immunoglobulin G following enzymic digestion: a time study. Biochim Biophys Acta (1969) 0.97
Endothelial injury and repair in systemic vasculitis of the young. Arthritis Rheum (2010) 0.97
The kinetics of oral hyposensitization to a protein antigen are determined by immune status and the timing, dose and frequency of antigen administration. Immunology (1989) 0.97
Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia. Semin Hematol (2001) 0.96
Studies on the immunology of human malaria. II. Characterization of antibodies to Plasmodium falciparum infections. Clin Exp Immunol (1969) 0.96
Fluoroscopic manipulation of Tenckhoff catheters: outcome analysis. Clin Nephrol (1997) 0.96
Studies on the levels of immunoglobulins in normal human urine with particular reference to IgE. Int Arch Allergy Appl Immunol (1970) 0.96
HLA, atopy, and cyclophosphamide in steroid-responsive childhood nephrotic syndrome. Kidney Int (1980) 0.96
Treatment of advanced stage T cell lymphoblastic lymphoma: results of the United Kingdom Children's Cancer Study Group (UKCCSG) protocol 8503. Br J Haematol (1992) 0.96
Few food diets in the treatment of atopic eczema. Arch Dis Child (1989) 0.95
Suboptimal C3b/C3bi deposition and defective yeast opsonization. II. Partial purification and preliminary characterization of an opsonic co-factor able to correct sera with the defect. Clin Exp Immunol (1985) 0.95